The Female Health Company Schedules First Quarter FY2010 Conference Call for February 8, 2010
January 28 2010 - 7:30AM
PR Newswire (US)
CHICAGO, Jan. 28 /PRNewswire-FirstCall/ -- The Female Health
Company (NASDAQ:FHCO) today announced that it will host an investor
conference call to discuss its operating results for the first
quarter of FY2010 on Monday, February 8, 2010 at 11:00 a.m. EST.
The Company expects to report its operating results earlier the
same day. Shareholders and other interested parties may participate
in the conference call by dialing 800-860-2442 (international
participants dial 412-858-4600) and asking to be connected to "The
Female Health Company Conference Call" a few minutes before 11:00
a.m. EST on February 8, 2010. A replay of the call will be
available one hour after the call through 5:00 p.m. EST on Monday,
February 22, 2010 by dialing 877-344-7529 (international callers
dial 412-317-0088) and entering the conference ID 437017. About The
Female Health Company The Female Health Company, based in Chicago,
Illinois, manufactures and markets the FC2 Female Condom® (FC2),
which is distributed primarily by public health organizations and
donor groups in about 100 countries around the world. The Company
owns certain worldwide rights to the FC2 Female Condom®, including
patents that have been issued in Europe, Canada, Australia, South
Africa and Japan and are pending in various other countries. FC2
Female Condom® is the only available FDA-approved product
controlled by a woman that offers dual protection against sexually
transmitted diseases, including HIV/AIDS, and unintended pregnancy.
The World Health Organization (WHO) has cleared FC2 for purchase by
U.N. agencies. For more information about the Female Health Company
visit the Company's website at http://www.femalehealth.com/ and
http://www.fc2femalecondom.com/. If you would like to be added to
the Company's e-mail alert list, please send an e-mail to . "Safe
Harbor" statement under the Private Securities Litigation Reform
Action of 1995: The statements in this release which are not
historical facts are forward-looking statements based upon the
Company's current plans and strategies, and reflect the Company's
current assessment of the risks and uncertainties related to its
business, including such things as product demand and market
acceptance; the economic and business environment and the impact of
government pressures; currency risks; capacity; efficiency and
supply constraints; and other risks detailed in the Company's press
releases, shareholder communications and Securities and Exchange
Commission filings. Actual events affecting the Company and the
impact of such events on the Company's operations may vary from
those currently anticipated. Contacts: William R. Gargiulo, Jr.
231-526-1244 Donna Felch, CFO 312-595-9123 DATASOURCE: The Female
Health Company CONTACT: William R. Gargiulo, Jr., +1-231-526-1244,
or Donna Felch, CFO, +1-312-595-9123, both of The Female Health
Company Web Site: http://www.femalehealth.com/
Copyright